C&S introduced oil painting-effect products creating high-end brand positioning Special Focus: How Chinese tissue performed in 2021- and its development targets for 2022​

The Covid-19 pandemic has accelerated the intellectualisation of tissue machinery across the world, and no more so than in China. Here, in a comprehensive report, the National Household Paper Industry Association (CNHPIA) examines that and the many other trends in the Chinese market for TWM. In 2021 the total capacity for the Chinese tissue paper market was nearly 2.6m tonnes. While there are some projects that have been put into operation but not announced, this new total 2021 capacity figure significantly exceeds that of 2020. A total of 62 companies in 16 provinces launched new tissue capacity, and 112 tissue machines across the country were put into operation during 2021. Located mainly in Hebei and Guangxi, these major projects of top enterprises totalled more than 880,000 tonnes of new capacity. In addition to the launched capacity, many new capacity expansion projects have also been signed. The planned new capacity announced by top companies such as Hengan, Vinda, C&S and Gold Hongye totalled more than three million tonnes. Moreover, companies that already have a presence in the papermaking industry chain such as Asia Symbol and Shanying International have recently announced new tissue paper projects to mark their entry into the industry.

C&S plans tissue expansion in Hebei; small mills in Mancheng forced to stop to combat smog

(News from RISI) – C&S Paper is to add 75,000tpy of new tissue paper capacity at its mill in Tangshan city, Hebei province, to feed increasing demand in northern and northeastern China. The board of directors of the Shenzhen-listed company approved the expansion plan in November. The project will involve a total investment of RMB 408.81 million and is expected to be finished in three years. A company spokesperson said the scheme is at an early planning stage and declined to disclose more detail. C&S Paper operates six mills with a combined capacity of 466,000tpy, making it the fourth largest tissue producer in China. The Tangshan plant is its only production site in North China; it currently houses just one tissue machine. The 25,000tpy unit, supplied by Toscotec, was commissioned in 2012. Back in 2010 when the company made its initial public offering on the Shenzhen stock exchange, it originally planned to install three tissue units with a total capacity of 50,000tpy at Tangshan. A year later the scheme was revised to one machine, due to lukewarm demand in the north at that time.